title: Do zinc and selenium prevent the antioxidant, hepatic and renal system impairment caused by aspirin in rats?
abstract: Aspirin is widely used as an antiinflammatory drug especially in children with rheumatic fever arthritis. The diminishing effects of aspirin on antioxidant enzymes and hepato-renal systems at high doses are well-known. It is now evident that the damage at antioxidant system worsens the clinical picture of the disease and prolongs the treatment time. Thus, we investigated the effect of antioxidant enzyme cofactors-zinc and selenium-supplementation on superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels (erythrocyte and liver) and hepato-renal toxicity during aspirin treatment at therapeutic doses. The rats were divided into five groups. The first and second groups were given aspirin 75 mg/kg/day and aspirin plus selenium (Selenium 200, selenium 200 mg tablet as selenium yeast, GNC) and zinc (Zinc 100, zinc 100 mg tablet as zinc gluconate, GNC), respectively, the third and fourth take 50 mg/kg/day aspirin and aspirin plus selenium and zinc twice a day, respectively. The fifth group was control. The rats were treated with aspirin for 5 weeks as in the treatment of rheumatic fever arthritis in children. Erythrocyte SOD and MDA levels were preserved with supplementation, whereas there was no change for GSH-Px levels. Liver SOD, GSH-Px, and MDA levels were not changed. In zinc- and selenium-supplemented groups, the levels of serum alanine aminotransferase, uric acid, and direct bilirubin levels were found statistically decreased compared with nonsupplemented groups. There was no significant histopathologic change in specimens of hepatic and renal tissues. Trace element supplementation may prevent free radical damage and shorten treatment time in children using long-term aspirin treatment.
authors.affiliation: Department of Pediatrics, School of Medicine, Gulhane Military Medical Academy, Etlik, 06018, Ankara, Turkey. vural73@yahoo.com
authors.forename: Vural
authors.initials: V
authors.lastname: Kesik
authors.forename: Mustafa Koray
authors.initials: MK
authors.lastname: Lenk
authors.forename: Ahmet Emin
authors.initials: AE
authors.lastname: Kurekci
authors.forename: Cengiz Han
authors.initials: CH
authors.lastname: Acikel
authors.forename: Emin Ozgur
authors.initials: EO
authors.lastname: Akgul
authors.forename: Ahmet
authors.initials: A
authors.lastname: Aydin
authors.forename: Onur
authors.initials: O
authors.lastname: Erdem
authors.forename: Mehmet
authors.initials: M
authors.lastname: Gamsizkan
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D001241:Aspirin / Q000009:adverse effects*; D005979:Glutathione Peroxidase / Q000378:metabolism; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000008:administration & dosage*; D013482:Superoxide Dismutase / Q000378:metabolism; D015032:Zinc / Q000008:administration & dosage*
chemical_list: D000975:Antioxidants; D008315:Malondialdehyde; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D012643:Selenium; D015032:Zinc; D001241:Aspirin